Literature DB >> 9721910

Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury.

B R Pike1, X Zhao, J K Newcomb, R M Posmantur, K K Wang, R L Hayes.   

Abstract

Activity of calpains and caspase-3 inferred from proteolysis of the cytoskeletal protein alpha-spectrin into signature spectrin breakdown products (SBDPs) was used to provide the first systematic and simultaneous comparison of changes in activity of these two families of cysteine proteases after traumatic brain injury (TBI) in rats. Distinct regional and temporal patterns of calpain/caspase-3 processing of alpha-spectrin were observed in brain regions ipsilateral to the site of injury after TBI, including large increases of 145 kDa calpain-mediated SBDP in cortex (up to 30-fold), and enduring increases (up to 2 weeks) of 145 kDa SBDP in hippocampus and thalamus. By contrast, 120 kDa caspase-3-mediated SBDP was absent in cortex and showed up to a 2-fold increase in hippocampus and striatum at early (hours) after TBI. Future studies will clarify the pathological significance of large regional differences in activation of calpain and caspase-3 proteases after TBI.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721910     DOI: 10.1097/00001756-199808030-00002

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  50 in total

1.  In vitro stretch injury induces time- and severity-dependent alterations of STEP phosphorylation and proteolysis in neurons.

Authors:  Mahlet N Mesfin; Catherine R von Reyn; Rosalind E Mott; Mary E Putt; David F Meaney
Journal:  J Neurotrauma       Date:  2012-06-25       Impact factor: 5.269

2.  Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats.

Authors:  Erik A Johnson; Stanislav I Svetlov; Kevin K W Wang; Ronald L Hayes; Jose A Pineda
Journal:  Exp Brain Res       Date:  2005-10-29       Impact factor: 1.972

Review 3.  Investigation of nerve injury through microfluidic devices.

Authors:  Rezina Siddique; Nitish Thakor
Journal:  J R Soc Interface       Date:  2013-11-13       Impact factor: 4.118

Review 4.  Neuroprotection and acute spinal cord injury: a reappraisal.

Authors:  Edward D Hall; Joe E Springer
Journal:  NeuroRx       Date:  2004-01

5.  A novel strategy to activate cytoprotective genes in the injured brain.

Authors:  Jing Zhao; John B Redell; Anthony N Moore; Pramod K Dash
Journal:  Biochem Biophys Res Commun       Date:  2011-03-22       Impact factor: 3.575

6.  Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.

Authors:  Ayman G Mustafa; Juan A Wang; Kimberly M Carrico; Edward D Hall
Journal:  J Neurochem       Date:  2011-03-22       Impact factor: 5.372

Review 7.  Current status of fluid biomarkers in mild traumatic brain injury.

Authors:  Jacqueline R Kulbe; James W Geddes
Journal:  Exp Neurol       Date:  2015-05-14       Impact factor: 5.330

8.  Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.

Authors:  Hussein Abou-Abbass; Hisham Bahmad; Hadi Abou-El-Hassan; Rui Zhu; Shiyue Zhou; Xue Dong; Eva Hamade; Khalil Mallah; Abir Zebian; Naify Ramadan; Stefania Mondello; Jawad Fares; Youssef Comair; Samir Atweh; Hala Darwish; Kazem Zibara; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-03-29       Impact factor: 3.535

9.  Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay.

Authors:  Supriti Samantaray; Joshua A Smith; Arabinda Das; Denise D Matzelle; Abhay K Varma; Swapan K Ray; Naren L Banik
Journal:  Neurochem Res       Date:  2011-05-25       Impact factor: 3.996

10.  Spillway-induced salmon head injury triggers the generation of brain alphaII-spectrin breakdown product biomarkers similar to mammalian traumatic brain injury.

Authors:  Ann Miracle; Nancy D Denslow; Kevin J Kroll; Ming Cheng Liu; Kevin K W Wang
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.